Antipsychotic drug use and the risk of venous thromboembolism in elderly patients

Journal of Clinical Psychopharmacology

Volumn 30, Issue 5, 2010, Pages 526-530

  Kleijer, Bart C ^a,b   Heerdink, Eibert R ^c   Egberts, Toine C G ^b,c   Jansen, Paul A F ^b   Van Marum, Rob J ^b,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

adverse effects; aged; antipsychotic drugs; risk factors; venous thrombosis

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; OLANZAPINE; PERICIAZINE; PERPHENAZINE; PIPAMPERONE; QUETIAPINE; RISPERIDONE; SULPIRIDE; TIAPRIDE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 77957252198     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181f0e87d     Document Type: Article

References (23)

1. Kaye JA, Bradbury BD, Jick H. Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. Br J Clin Pharmacol. 2003;56: 569-575. (Pubitemid 37386512)
2. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5: 692-699. (Pubitemid 46563566)
3. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360: 225-235.
4. Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146: 775-786. (Pubitemid 351650498)
5. Hagg S, Jonsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf. 2009;8: 537-547.
6. Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet. 2000;356: 1219-1223.
7. Kamijo Y, Soma K, Nagai T, et al. Acute massive pulmonary thromboembolism associated with risperidone and conventional phenothiazines. Circ J. 2003;67: 46-48. (Pubitemid 36119621)
8. Parkin L, Skegg DC, Herbison GP, et al. Psychotropic drugs and fatal pulmonary embolism. Pharmacoepidemiol Drug Saf. 2003;12: 647-652. (Pubitemid 38028778)
9. Lacut K, Le Gal G, Couturaud F, et al. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study. Fundam Clin Pharmacol. 2007;21: 643-650. (Pubitemid 350151244)
10. Hagg S, Spigset O, Soderstrom TG. Association of venous thromboembolism and clozapine. Lancet. 2000;355: 1155-1156. (Pubitemid 30172939)
11. Walker AM, Lanza LL, Arellano F, et al. Mortality in current and former users of clozapine. Epidemiology. 1997;8: 671-677. (Pubitemid 27449500)
12. Liperoti R, Pedone C, Lapane KL, et al. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med. 2005;165: 2677-2682. (Pubitemid 41785068)
13. Hagg S, Bate A, Stahl M, et al. Associations between venous thromboembolism and antipsychotics: a study of the WHO database of adverse drug reactions. Drug Saf. 2008;31: 685-694. (Pubitemid 352019566)
14. Ray JG, Mamdani MM, Yeo EL. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism. Thromb Haemost. 2002;88: 205-209. (Pubitemid 34873699)
15. Alanen HM, Finne-Soveri H, Noro A, et al. Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland. Age Ageing. 2006;35: 508-513. (Pubitemid 44295640)
16. Wolstein J, Grohmann R, Ruther E, et al. Antipsychotic drugs and venous thromboembolism. Lancet. 2000;356: 252-253.
17. Carrizo E, Fernandez V, Quintero J, et al. Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives. Schizophr Res. 2008;103: 83-93.
18. Herings R. PHARMO: a Record Linkage System for Postmarketing Surveillance of Prescription Drugs in the Netherlands [thesis]. Utrecht, The Netherlands: Utrecht University; 1993.
19. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry. 1999;60(suppl 10): 5-14. (Pubitemid 29237170)
20. Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000;68: 29-39.
21. Lopez-Jimenez L, Montero M, Gonzalez-Fajardo JA, et al. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE). Haematologica. 2006;91: 1046-1051. (Pubitemid 44204770)
22. Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost. 1999;82: 610-619.
23. Rosendaal FR, Van HV, Doggen CJ. Venous thrombosis in the elderly. J Thromb Haemost. 2007;5(suppl 1): 310-317.